Results 91 to 100 of about 4,240 (196)

[Stenosing esophagitis in Zollinger-Ellison syndrome].

, 1994
International audienceThree patients with the Zollinger-Ellison syndrome and severe oesophagitis are reported. Intractable oesophageal stricture developed, leading to oesophago-gastrectomy in two patients and iterative oesophageal dilatations in the ...
Riché, A., Hélie, C., Vallot, T., Cosnes, J., Cadiot, G., Mignon, M., Marmuse, J. P.   +6 more
core  

Bilateral Extraocular Muscle Metastases in Zollinger-Ellison Syndrome

, 1994
In Zollinger-Ellison syndrome, gastric, duodenal, and jejunal ulcers are associated with gastrinsecreting non-β-islet cell tumors of the pancreas (gastrinomas).1 The tumors may arise in multiple sites (multifocal endocrine neoplasia type I),1 and ...
Liu, Grant T, Tse, David T, Schatz, Norman J, Curtin, Victor T   +3 more
core   +1 more source

Zollinger-Ellison Syndrome: A Narrative Review of Clinical Presentation, Pathogenesis, Diagnosis and Modern Management Approaches [PDF]

Journal of Clinical and Diagnostic Research
Zollinger-Ellison Syndrome (ZES) is rare disorder which is caused by gastrin-secreting neuroendocrine tumours known as gastrinomas, primarily located in the duodenum or pancreas.
Jaideep Reddy, Raju Shinde, Khushbu Vaidya, Prithvansh Malhotra, Bhagyesh Sapkale   +4 more
doaj   +1 more source

Duodenal gastrinomas, duodenotomy, and duodenal exploration in the surgical management of Zollinger-Ellison syndrome [PDF]

, 1993
Studies have shown that the duodenum is a more common site (30–40%) of primary gastrinomas than previously reported. These tumors are often occult to conventional exploration, and their detection requires duodenotomy and meticulous evaluation of the ...
Fukuuchi, Atsushi, Pasieka, Janice L., Thompson, Norman W.   +2 more
core   +1 more source

Zollinger-Ellison syndrome [PDF]

Revista Española de Enfermedades Digestivas, 2013
Alventosa-Mateu, Carlos, Ferrer-Barceló, Luis, Huguet-Malavés, Jose María, Ferrer-Arranz, Luis, Monzó-Gallego, Ana, Medina-Chuliá, Enrique   +5 more
openaire   +4 more sources

Current Concepts on Gastric Carcinoid Tumors

Gastroenterology Research and Practice, 2012
Gastric carcinoid tumors (GCs) are rare lesions representing less than 10% of carcinoid tumors and less than 1% of all stomach neoplasms. There are three distinct types of gastric carcinoids; type I includes the vast majority (70–85%) of these neoplasms ...
George C. Nikou, Theodoros P. Angelopoulos   +1 more
doaj   +1 more source

Síndrome de Zollinger - Ellison

, 1978
The latesf knowledge on the pathology diagnosis ánd treatment of the Zollinger - Ellison syndrome are considered. This is the first time in our experiencethat the pancreatic tumour and -its hepatic metastasis has been clinicaUy observed in
Touya, Eduardo, Bertullo, Hugo, Perdomo, Roberto, Pizzarrosa, Carlos, Otegui, Ismael, Roble, Ana M, Geninazzi, Héctor, Liard, Washington, Aguirre de García, Beatriz   +8 more
core  

Zollinger-Ellison Syndrome in Three Dogs

, 1980
The main clinical signs of three dogs with Zollinger-Ellison syndrome were vomiting, diarrhoea, poor appetite and weight loss. The diagnosis was confirmed by histological examination and by gastrin immunocytochemistry.
C.B.H.W. Lamers, I. Van Der Gaag, L.I. Larsson, J. F. Rehfeld, J. Van Toorenburg, R. P. Happé   +5 more
core   +1 more source

Review: A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers

Therapeutic Advances in Gastroenterology, 2010
Intravenous (IV) proton-pump inhibitors (PPIs) are potent gastric acid suppressing agents, and their use is popular in clinical practice. Both IV and oral PPIs have similarly short half-lives, and their effects on acid secretion are similar, thus their ...
Sandy H. Pang, David Y. Graham
doaj   +1 more source

Balancing therapeutic benefits and hidden risks of proton pump inhibitors in pediatric practice: a narrative review and update [PDF]

Clinical and Experimental Pediatrics
Proton pump inhibitors (PPIs) are drugs whose main effect is catalytic and long-lasting suppression of gastric acid secretion, with an anti-inflammatory effect.
Maria Rogalidou, Alexandra Papadopoulou
doaj   +1 more source